Huachansu suppresses human bladder cancer cell growth through the Fas/Fasl and TNF- alpha/TNFR1 pathway in vitro and in vivo
Open Access
- 25 February 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Experimental & Clinical Cancer Research
- Vol. 34 (1), 1-10
- https://doi.org/10.1186/s13046-015-0134-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The Fas/Fas Ligand Death Receptor Pathway Contributes to Phenylalanine-Induced Apoptosis in Cortical NeuronsPLOS ONE, 2013
- Anti-Angiogenic Effects of the Superantigen Staphylococcal Enterotoxin B and Bacillus Calmette-Guérin Immunotherapy for Nonmuscle Invasive Bladder CancerJournal of Urology, 2012
- Caspase-8 activity has an essential role in CD95/Fas-mediated MAPK activationCell Death & Disease, 2011
- Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans CantorInternational Immunopharmacology, 2011
- Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas‐ and mitochondria‐mediated pathwaysCancer Science, 2011
- Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall‐cell lung cancer, or pancreatic cancerCancer, 2009
- Experimental rat bladder urothelial cell carcinoma modelsWorld Journal of Urology, 2009
- The inhibitors of apoptosis (IAPs) as cancer targetsApoptosis, 2007
- Simultaneous determination of cytotoxic bufadienolides in the Chinese medicine ChanSu by high-performance liquid chromatography coupled with photodiode array and mass spectrometry detectionsJournal of Chromatography B, 2006
- Signalling pathways of the TNF superfamily: a double-edged swordNature Reviews Immunology, 2003